Summary
Bone Gla protein (BGP) was measured in the plasma by radioimmunoassay (RIA) during treatment of 59 patients with bone diseases including Paget's disease (N=9), primary hyperparathyroidism (N=25), chronic renal failure (N=20), and cancer involving bone (N=5). Plasma BGP was increased above normal in all patients. BGP decreased in the patients with Paget's disease following the acute and chronic administration of salmon calcitonin. Plasma BGP was higher in women then in men with primary hyperparathyroidism. Following parathyroidectomy, BGP decreased in both sexes but the decrease was significant in women only. Plasma BGP was increased in patients with renal osteodystrophy and did not change after hemodialysis. In the patients with bone cancer, plasma BGP decreased during treatment of the attendant hypercalcemia with salmon calcitonin. Although plasma BGP and serum alkaline phosphatase (AP) levels were generally correlated in these studies, there were examples of dissociation between the two. The measurement of plasma BGP appears to provide a specific index of bone metabolism that may in some circumstances be more sensitive than serum alkaline phosphatase measurement. However, further studies are necessary to establish the clinical value of plasma BGP measurement by RIA in the management of patients with bone diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism. J Clin Invest 66:878–883
Price PA, Nishimoto SK (1980) Radioimmunoassay for the vitamin K-dependent bone protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77:2234–2238
Hauschka PV, Lian JB, Gallop PM (1975) Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc Nat Acad Sci USA 72:3925–3929
Price PA, Otsuka AS, Poster JW, Kristaponis J, Raman N (1976) Characterization of a γ-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 73:1447–1451
Gallop PM, Lian JD, Hauschka PV (1980) Carboxylated calcium binding protein and vitamin K. N Engl J Med 302:1460–1466
Price PA, Baukol SA (1980) 1,25-Dihydroxyvitamin D increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. Biol Chem 255:11660–11663
Lian JB, Reit B, Roufosse AH, Glimcher MJ, Gallop PM (1979) Osteocalcin content in normal, rachitic, and vitamin K-antagonized bone. In: JW Suttie (ed) Vitamin K Metabolism and Vitamin K-Dependent Proteins. University Park Press, Baltimore, pp 237–244
Price PA, Poser JW, Raman N (1976) Primary structure of the γ-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci USA 73:3374–3375
Gundberg CM, Lian JB, Gallop PM (1979) γ-Carboxyglutamate analysis by selective anion exchange elution and fluorescent detection. Anal Biochem 98:219–225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deftos, L.J., Parthemore, J.G. & Price, P.A. Changes in plasma bone GLA protein during treatment of bone disease. Calcif Tissue Int 34, 121–124 (1982). https://doi.org/10.1007/BF02411221
Issue Date:
DOI: https://doi.org/10.1007/BF02411221